ข่าวประชาสัมพันธ์ Coronary Heart Disease+cardiovascular risk

DATA DEMONSTRATE IMPACT OF WEIGHT LOSS WITH SIBUTRAMINE ON CARDIOVASCULAR RISK FACTORS FOR OBESE PATIENTS

Bangkok--Jun 4--Weber Shandwick (Thailand) Data Address Positive Impact of Weight Loss with Sibutramine On Cardiovascular Risk Factors of Metabolic Syndrome, Left Ventricular Mass, and Predicted Risk of Coronary Heart Disease Data presented on May 26, 2004 at the 13th European Congress on Obesity explored the reduction of cardiovascular risk factors associated with being obese among patients who lost weight with sibutramine treatment. The data presented at the congress demonstrated the

04 มิถุนายน 2547 09:00 น.

Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial

Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major... มิ.ย. 62

American College of Cardiology recommends empagliflozin as preferred SGLT2 inhibitor for adults with type 2 diabetes and established cardiovascular disease in new Expert Consensus Decision Pathway

A new Expert Consensus Decision Pathway issued by the American College of Cardiology (ACC) recommends... พ.ย. 61

Latest state-of-the-art health check-up technology comes to Thailand — Verita Health MahaNakhon (VMH) is introducing "Verita Wisdom", a new 360° state-of-... ต.ค. 61

Ozempic(R) Consistently Reduced the Risk of Major Cardiovascular Events Across Type 2 Diabetes Populations at High CV Risk Regardless of Prior CV Events at Baseline

Ozempic(R) (semaglutide) consistently reduced the risk of the composite outcome of time to first occurrence of non-fatal heart attack,... ส.ค. 61

Interim Results of First-Ever Global Survey Show People with Type 2 Diabetes Underestimate their Cardiovascular Risk

- Globally, cardiovascular disease (CVD) is the most common cause of death in people with type 2 diabetes[1] - 1 in 3 respondents considered themselves to be at low risk of CVD[2] - 1... ธ.ค. 60

New Insights Link Low HDL-Cholesterol and Elevated Triglycerides With Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol

- Surveys Establish Residual Vascular Risk is Associated With Atherogenic Dyslipidemia Suggesting the Need to Reconsider Approach to... ก.ย. 52

Experts and Representatives From Leading International Health-Care Organizations Call to Stop the Hypertension Pandemic, a Worldwide Silent Killer

A Working Group of representatives from seven international health-care organizations call for improved blood pressure (BP) goal rate levels of patients... ก.พ. 51

New Data Show Xenical(R) Significantly Reduces Cardiovascular Risk and More Than Doubles Weight Loss Achieved in Overweight and Obese People

The weight loss medication Xenical(R) (orlistat 120mg) significantly reduces weight and improves cardiovascular risk factors such as blood pressure, glycaemic... เม.ย. 50

First Study to Show Positive Benefit on Atherosclerosis for People With Early Signs of Diseased Arteries

- METEOR Trial Shows CRESTOR Slowed Progression of Atherosclerosis in People at Low-Risk of Coronary Heart Disease (Framingham 10... มี.ค. 50